Behavior therapy and sibutramine for the treatment of adolescent obesity: a randomized controlled trial
You can read the full article at Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial This study investigated the effects of tirzepatide, a medication used to treat type 2 diabetes, on the bodys physiological mechanisms
According to the FDA, these medications were first used to help people with diabetes
Bays, who is also the Obesity Medicine Association's chief science officer, helped run studies of the drug
Zepbound: Targeting Dual Hormones For individuals aiming for substantial weight loss results, Zepbound might be the option